Julia Fehniger

ORCID: 0000-0003-1773-7060 · 2 papers in corpus
2024
TP005/#1564  Gog-3069: phase 2 study of alpelisib and fulvestrant for PIK3CA-mutated estrogen receptor-positive endometrioid endometrial cancers
·doi:10.1136/ijgc-2024-igcs.607
case-report 2019
Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapy
Gynecologic oncology reports ·doi:10.1016/j.gore.2018.11.004

We describe a case of the first successful treatment of platinum refractory clear cell ovarian cancer with secondary cytoreductive surgery and placement of Calypso transponders to facilitate post-operative volumetric arc radiation therapy. …